Ponte Biosciences, Inc. is a preclinical biotherapeutic company focused on developing a cell-based bioartificial liver system to treat acute forms of liver failure. The Company's Spheroid Reservoir Bioartificial Liver (SRBAL) system was developed at the Mayo Clinic and utilizes metabolically active primary hepatocytes (liver cells) to replace and/or supplement liver function for patients with liver failure being treated in the Intensive Care Unit (ICU).
Company Details
- Employees
- 5
- Founded
- -
- Address
- 3555 9th St Nw,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.pontebiosciences.com
- Keywords
- NovaGyn.
- HQ
- Rochester, MN
Ponte Biosciences, Inc. Questions
Ponte Biosciences, Inc.'s website is http://www.pontebiosciences.com
Ponte Biosciences, Inc.'s LinkedIn profile is https://www.linkedin.com/company/ponte-biosciences
Ponte Biosciences, Inc. has
5 employees.
View email and phone details for 5
employees at Ponte Biosciences, Inc..
Ponte Biosciences, Inc.'s industry is
Biotechnology Research
Ponte Biosciences, Inc.'s top competitors are
Amiracore,
Amicii,
Cortex Clinical Solutions,
Ambys Medicines,
Novagyn,
Newlimit,
Heart Failure Solutions,
Anser Implants,
Mill Creek Life Sciences,
Cytotheryx, Inc..
Ponte Biosciences, Inc.'s categories are Biotechnology Research
Ponte Biosciences, Inc.'s founding year is 2022
